Trial Profile
Drug Utilization Study for Lisdexamfetamine Dimesilate in Australia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2016
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 11 Nov 2016 New trial record